United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
299.42
-2.99 (-0.99%)
At close: Aug 7, 2025, 4:00 PM
299.59
+0.17 (0.06%)
Pre-market: Aug 8, 2025, 5:15 AM EDT
Longboard Pharmaceuticals Employees
United Therapeutics had 1,305 employees as of December 31, 2024. The number of employees increased by 137 or 11.73% compared to the previous year.
Employees
1,305
Change (1Y)
137
Growth (1Y)
11.73%
Revenue / Employee
$2,358,467
Profits / Employee
$951,801
Market Cap
13.54B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,305 | 137 | 11.73% |
Dec 31, 2023 | 1,168 | 183 | 18.58% |
Dec 31, 2022 | 985 | 20 | 2.07% |
Dec 31, 2021 | 965 | 15 | 1.58% |
Dec 31, 2020 | 950 | 30 | 3.26% |
Dec 31, 2019 | 920 | 60 | 6.98% |
Dec 31, 2018 | 860 | 60 | 7.50% |
Dec 31, 2017 | 800 | 50 | 6.67% |
Dec 31, 2016 | 750 | 0 | - |
Dec 31, 2015 | 750 | 10 | 1.35% |
Dec 31, 2014 | 740 | 34 | 4.82% |
Dec 31, 2013 | 706 | 83 | 13.32% |
Dec 31, 2012 | 623 | 80 | 14.73% |
Dec 31, 2011 | 543 | 23 | 4.42% |
Dec 31, 2010 | 520 | 110 | 26.83% |
Dec 31, 2009 | 410 | 50 | 13.89% |
Dec 31, 2008 | 360 | 40 | 12.50% |
Dec 31, 2007 | 320 | 35 | 12.28% |
Dec 31, 2006 | 285 | 75 | 35.71% |
Dec 31, 2005 | 210 | 40 | 23.53% |
Dec 31, 2004 | 170 | 10 | 6.25% |
Dec 31, 2003 | 160 | 10 | 6.67% |
Dec 31, 2002 | 150 | 22 | 17.19% |
Dec 31, 2001 | 128 | 18 | 16.36% |
Dec 31, 2000 | 110 | 47 | 74.60% |
Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
UTHR News
- 6 days ago - United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program - Business Wire
- 8 days ago - United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results - Business Wire
- 22 days ago - United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025 - Business Wire
- 6 weeks ago - United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver - Business Wire
- 6 weeks ago - United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension - Business Wire
- 2 months ago - United Therapeutics: Tanking On Rival's PAH Data - I'd Consider Buying Stock - Seeking Alpha
- 3 months ago - United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call Transcript - Seeking Alpha